Compare Mondaycom Ltd (MNDY) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mondaycom Ltd vs Tempus AI — how do they compare? Mondaycom Ltd trades at $89 (market cap $3.76B), while Tempus AI trades at $70.25 (market cap $12.58B). The key difference: Tempus AI is far larger — about 3.3× Mondaycom Ltd's market cap, and Tempus AI is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mondaycom Ltd for 16 Days and Tempus AI for 22 Days on average.
| MNDY | TEM | |
|---|---|---|
Market Cap | $3.76B | $12.58B |
Volume | 836,200 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $205.24 | $99.28 |
52-Week Low | $58.81 | $41.55 |
Typical Hold Time | 16 Days | 22 Days |
Enterprise Value | $2.92B | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MNDY trades at $83.51, down 0.93% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The company maintains strong profitability with 88.74% gross margins and has exceeded EPS expectations for three consecutive quarters. Recent news highlights inclusion in growth stock lists and positive analyst sentiment, while the upcoming Q3 2026 earnings report (expected EPS $1.37) will be a key catalyst.
The outlook remains positive with 65% analyst buy ratings and a $110.42 consensus price target suggesting 32% upside potential. Risks include elevated valuation multiples (P/E 37.69), competitive pressures from enterprise software rivals, and the technical bearish signal. Strong enterprise customer growth and AI integration through the Elevate '26 conference provide growth catalysts.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
